Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 1 Study of SSS17 in Healthy Chinese Adults
NCT04893187Phase 1Unknown
- Sponsor
- 3SBio
- Start
- Jul 2021
- Primary completion
- Dec 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial of SSS-17 in anemia (6 arms), sponsored by 3SBio. Primary endpoints: Adverse Events (AEs), Maximum plasma concentration (Cmax) of SSS17 and 10 more. Status: unknown.
02
Drugs
SSS-17
03
Conditions
anemia
Beyond the preview
Go deeper on NCT04893187.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04893187.